3Schiff ER,Lee SS,Chao YC,et al.Long-term treatment with ente-cavir induces reversal of advanced fibrosis or cirrhosis in patientswith chronic hepatitis B[J].Clin Gastroenterol Hepatol,2011,9(3):274-276.
4Friedman SL.Mac the knife?Macrophages-the double-edgedsword of hepatic fibrosis[J].J Clin Invest,2005,115(1):29-32.
5Tsukada S,Parsons CJ,Rippe RA.Mechanisms of liver fibrosis[J].Clin Chim Acta,2006,364(1-2):33-60.
6Suzuki A,Angulo P,Lymp J,et al.Hyaluronic acid,an accurateserum marker for severe hepatic fibrosis in Patients with nonalco-holic fatty liver disease[J].Liver Int,2005,25(4):779-786.
7Nobili V,Alisi A,Torre G,et al.Hyaluronic acid predicts hepaticfibrosis in children with nonalcoholic fatty liver disease[J].Transl Res,2010,156(4):229-234.
8Chen G,Lin W,Shen F,et al. Past HBV viral load as predic- tor of mortality and morbidity from HCC and chronic liver dis- ease in a prospective study.Am J Gastroenterol,2006,101(8): 1797-1803.
9Leung N,Peng CY,Hann HW,el al.Early hepatitis B virus DNA reduction in hepatitis B e antigen positive patients with chronic hepatitis B:A randomized international study of entecavir versus adefovir.Hepatology, 2009,49( 1 ) : 72-79.
